PubRank

Guenther Gastl

Author PubWeight™ 48.76‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 2005 4.02
2 Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003 3.44
3 High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 2004 2.14
4 CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J Am Soc Nephrol 2005 1.83
5 Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecol Oncol 2006 1.69
6 The effect of zoledronic acid on the function and differentiation of myeloid cells. Haematologica 2006 1.66
7 TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity. Mod Pathol 2007 1.63
8 EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis. J Clin Pathol 2011 1.46
9 Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res 2004 1.46
10 GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomib. Blood 2009 1.37
11 Low concentrations of STI571 in the cerebrospinal fluid: a case report. Br J Haematol 2002 1.27
12 The kinase inhibitor imatinib mesylate inhibits TNF-{alpha} production in vitro and prevents TNF-dependent acute hepatic inflammation. Proc Natl Acad Sci U S A 2005 1.23
13 High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Oral Oncol 2006 1.18
14 Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors. Biochem Biophys Res Commun 2007 1.16
15 Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue. Cancer Lett 2006 1.07
16 Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile. Cancer 2004 1.05
17 Phenotype-dependent effects of EpCAM expression on growth and invasion of human breast cancer cell lines. BMC Cancer 2012 1.03
18 Effects of EpCAM overexpression on human breast cancer cell lines. BMC Cancer 2011 1.00
19 RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines. Exp Hematol 2005 0.97
20 Increased angiogenesis in chronic idiopathic myelofibrosis: vascular endothelial growth factor as a prominent angiogenic factor. Hum Pathol 2007 0.95
21 The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. J Immunol 2009 0.93
22 Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer. Ann Surg Oncol 2012 0.92
23 Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation 2003 0.92
24 Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas. J Clin Pathol 2014 0.91
25 Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer. Histopathology 2013 0.90
26 STAT1 activation in squamous cell cancer of the oral cavity: a potential predictive marker of response to adjuvant chemotherapy. Cancer 2007 0.90
27 EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features. Oral Oncol 2007 0.89
28 (68)Ga-DOTATOC PET/CT provides accurate tumour extent in patients with extraadrenal paraganglioma compared to (123)I-MIBG SPECT/CT. Eur J Nucl Med Mol Imaging 2014 0.88
29 Measurement of cyclin E genomic copy number and strand length in cell-free DNA distinguish malignant versus benign effusions. Clin Cancer Res 2007 0.87
30 EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth. Mol Cancer 2013 0.87
31 Role of forkhead box protein 3 expression in invasive breast cancer. J Clin Oncol 2007 0.87
32 Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantation. Hum Pathol 2002 0.86
33 High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study. Haematologica 2010 0.85
34 Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions. Gynecol Oncol 2005 0.84
35 Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. Br J Haematol 2005 0.83
36 Phenotypic and functional deficiencies of leukaemic dendritic cells from patients with chronic myeloid leukaemia. Br J Haematol 2003 0.81
37 Hodgkin lymphoma in Tyrol-a population-based study. Ann Hematol 2008 0.79
38 Medical decision analysis for first-line therapy of chronic myeloid leukemia. Leuk Lymphoma 2014 0.77
39 Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features. Leuk Lymphoma 2005 0.76
40 Systematic assessment of decision-analytic models for chronic myeloid leukemia. Appl Health Econ Health Policy 2014 0.76
41 High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial. Haematologica 2012 0.75
42 Clinical aspects, diagnostic challenges and management of patients with neuroendocrine tumors (NETs). Onkologie 2011 0.75
43 Transition of idiopathic CD4 + lymphocytopenia into mycosis fungoides? Leuk Lymphoma 2013 0.75
44 Possible role for gene expression profiling in predicting responses to conventional or targeted drugs in patients with chronic myeloid leukemia. Leuk Lymphoma 2008 0.75
45 Synergistic and additive antiproliferative effects on human leukemia cell lines induced by combining acetylenehexacarbonyldicobalt complexes with the tyrosine kinase inhibitor imatinib. J Inorg Biochem 2006 0.75